keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Isoliquiritin apioside, isolated from Glycyrrhizae radix rhizome, significantly decreases PMA-induced increases in MMP9 activities and suppresses PMA-induced activation of MAPK and NF-κB. Isoliquiritin apioside auppresseses invasiveness and angiogenesis of cancer cells and endothelial cells. Isoliquiritin apioside has marked potential to combat oxidative stress-induced genotoxicity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 65.00 | |
5 mg | In stock | $ 148.00 | |
10 mg | In stock | $ 220.00 | |
25 mg | In stock | $ 375.00 | |
50 mg | In stock | $ 557.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 228.00 |
Description | Isoliquiritin apioside, isolated from Glycyrrhizae radix rhizome, significantly decreases PMA-induced increases in MMP9 activities and suppresses PMA-induced activation of MAPK and NF-κB. Isoliquiritin apioside auppresseses invasiveness and angiogenesis of cancer cells and endothelial cells. Isoliquiritin apioside has marked potential to combat oxidative stress-induced genotoxicity. |
Source |
Molecular Weight | 550.51 |
Formula | C26H30O13 |
CAS No. | 120926-46-7 |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5.5 mg/mL (10 mM), Sonification is recommended
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Isoliquiritin apioside 120926-46-7 MAPK NF-Κb Proteases/Proteasome MMP p38 MAPK NF-κB Inhibitor HT1080 Nuclear factor-kappaB inhibit HIF-1α cancer Nuclear factor-κB metastasis angiogenesis Matrix metalloproteinases inhibitor